Imfinzi and Back pain - a phase IV clinical study of FDA data

Summary:

Back pain is reported as a side effect among people who take Imfinzi (durvalumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Back pain when taking Imfinzi. It is created by eHealthMe based on reports of 8,352 people who have side effects when taking Imfinzi from the FDA, and is updated regularly.

What is Imfinzi?

Imfinzi has active ingredients of durvalumab. eHealthMe is studying from 8,353 Imfinzi users. Check the latest studies of Imfinzi.

What is Back pain?

Back pain is found to be associated with 3,223 drugs and 4,710 conditions by eHealthMe. Check the latest studies of Back pain.

On Jul, 09, 2026

8,352 people reported to have side effects when taking Imfinzi.
Among them, 50 people (0.6%) have Back pain.

Among these 50 people:

How long have people been on Imfinzi when they have Back pain? *

What is the gender of people who have Back pain when taking Imfinzi? *

female: 53.06 %
male: 46.94 %

What is the age of people who have Back pain when taking Imfinzi? *

What are other drugs people take besides Imfinzi? *

What are other side effects people have besides Back pain? *

Dyspnea (difficult or laboured breathing): 19 people, 38.00%
Fatigue (feeling of tiredness): 18 people, 36.00%
Hypotension (abnormally low blood pressure): 15 people, 30.00%
Cough: 15 people, 30.00%
Weakness: 13 people, 26.00%
Neck Pain: 12 people, 24.00%
Headache (pain in head): 10 people, 20.00%
Weight Decreased: 10 people, 20.00%
Nausea (feeling of having an urge to vomit): 9 people, 18.00%
Pneumonia: 9 people, 18.00%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 18 people, 36.00%
Lung Cancer - Non-Small Cell (lung cancer): 9 people, 18.00%
Non-Small Cell Lung Cancer Stage Iii: 5 people, 10.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 8.00%
High Blood Cholesterol: 4 people, 8.00%
High Blood Pressure: 4 people, 8.00%
Nausea (feeling of having an urge to vomit): 4 people, 8.00%
Abdominal Discomfort: 4 people, 8.00%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 4.00%
Stress And Anxiety: 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Imfinzi and have Back pain?

- Check whether Back pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imfinzi:

Imfinzi (8,353 reports)

Back pain treatments and more:

Back pain (379,875 reports)

Browse all side effects of Imfinzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain:

Back pain (3,223 drugs)

Browse all the conditions that are associated with Back pain:

Back pain (4,710 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on durvalumab (the active ingredients of Imfinzi) and Imfinzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.